Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction

Clinical trial NCT06961630 · RECRUITING

Trial details

NCT number: NCT06961630
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Myocardial Injury After Noncardiac Surgery

Start date: 2025-10-07
Primary completion: 2027-03-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.